High JAK2 Protein Expression Predicts a Poor Prognosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma.

Conclusions: Assessment of JAK2 protein expression may be a promising method to predict prognosis in patients with resectable PDAC. PMID: 33029256 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33029256?dopt=Abstract

Source: Disease Markers - October 9, 2020 Category: Laboratory Medicine Tags: Dis Markers Source Type: research